Displaying drugs 2201 - 2225 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Rebamipide | 370.79 C19H15ClN2O4 |  | A gastroprotective agent used in combination with other similar therapies (e.g. proton pump inhibitors) to treat gastritis and protect the gastric mucosa. | Anti-Ulcer Agents / Antioxidants / Enzyme Inhibitors |
| Reboxetine | 313.397 C19H23NO3 |  | A drug used for the acute treatment of major depression and for maintenance therapy of depression. | Adrenergic Uptake Inhibitors / Morpholines |
| Regadenoson | 390.354 C15H18N8O5 |  | A coronary vasodilator used in radionuclide myocardial perfusion imaging (MPI). | Adenosine A2 Receptor Agonists / Pharmacologic Cardiac Stress Test Agent / Purinergic P1 Receptor Agonists |
| Regorafenib | 482.815 C21H15ClF4N4O3 |  | A kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma. | Protein Kinase Inhibitors |
| Relebactam | 348.37 C12H20N4O6S |  | A beta-lactamase inhibitor used to prevent hydrolysis of beta-lactam antibiotics, leading to increased effectiveness. | beta-Lactamase Inhibitors |
| Relugolix | 623.64 C29H27F2N7O5S |  | An oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer. | Anti-Gonadotropin-Releasing Hormones |
| Remdesivir | 602.585 C27H35N6O8P |  | A nucleoside analog used to treat RNA virus infections including COVID-19. | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Remifentanil | 376.4467 C20H28N2O5 |  | An opioid analgesic used in anesthesia. | Opioid Anesthetics |
| Remimazolam | 439.313 C21H19BrN4O2 |  | An ultra short-acting benzodiazepine used for the induction and maintenence of procedural sedation during short procedures. | Benzodiazepines and benzodiazepine derivatives |
| Remoxipride | 371.269 C16H23BrN2O3 |  | An discontinued atypical antipsychotic selective for dopamine D2 receptors. | Benzamides and benzamide derivatives |
| Repaglinide | 452.5857 C27H36N2O4 |  | A antihyperglycemic used to improve glycemic control in diabetes. | Glinide / Stereoisomerism |
| Repotrectinib | 355.373 C18H18FN5O2 |  | A tyrosine kinase inhibitor used to treat locally active or metastatic non-small cell lung cancer | BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Inhibitors / Cytochrome P-450 CYP3A5 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Kinase Inhibitor / MATE 2 Inhibitors / MATE inhibitors / OATP1B1/SLCO1B1 Inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates / ROS1 tyrosine kinase inhibitors / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors |
| Rescinnamine | 634.716 C35H42N2O9 |  | For the treatment of hypertension. | Secologanin Tryptamine Alkaloids |
| Reserpine | 608.6787 C33H40N2O9 |  | For the treatment of hypertension | Secologanin Tryptamine Alkaloids |
| Resmetirom | 435.22 C17H12Cl2N6O4 |  | A thyroid hormone receptor-beta agonist used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis in adults. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / BSEP/ABCB11 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 inhibitors / OATP1B3 substrates / Pyrimidines / Pyrimidinones / Thyroid hormone receptor-beta (THR-beta) agonist / UGT1A4 Inhibitors / UGT1A9 Inhibitors |
| Resorcinol | 110.1106 C6H6O2 |  | Contemporary therapeutic uses for resorcinol primarily revolve around the use of the phenol derivative as an active ingredient in topical antiseptics [L2745, L2744, L40069, F61] or as topical antibacterial skin... | Root Canal Filling Materials |
| Resorcinol monoacetate | 152.149 C8H8O3 |  | Not Annotated | Benzene Derivatives / Phenols |
| Retapamulin | 517.763 C30H47NO4S |  | A topical antibiotic agent used for the treatment of impetigo caused by methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes. | Anti-Bacterial Agents / Pleuromutilin Antibacterial |
| Revefenacin | 597.76 C35H43N5O4 |  | An anticholinergic agent used to treat COPD. | Anticholinergic Agents / Bronchodilator Agents / Muscarinic Antagonists |
| Reviparin | Not Annotated |  | By the FDA, reviparin is indicated for the treatment of deep vein which may lead to pulmonary embolism in pediatric patients. It is also indicated for the long-term treatment of... | Anticoagulants |
| Rezafungin | 1226.411 C63H85N8O17 |  | An echinocandin antifungal indicated in patients over 18 years old who have limited or no alternative options for the treatment of candidemia and invasive candidiasis. | Antifungal Agents |
| Ribavirin | 244.2047 C8H12N4O5 |  | A guanosine nucleoside used to treat some forms of Hepatitis C. | Antivirals for treatment of HCV infections |
| Ribociclib | 434.548 C23H30N8O |  | A kinase inhibitor used to treat HR+, HER2- advanced or metastatic breast cancer. | Cyclin-dependent kinase (CDK) inhibitors / Protein Kinase Inhibitors |
| Riboflavin | 376.3639 C17H20N4O6 |  | A vitamin used to correct vitamin B2 deficiency. | Vitamins |
| Ribostamycin | 454.4727 C17H34N4O10 |  | A broad spectrum aminoglycoside antibiotic on the list of WHO critical antimicrobials for human medicine. | Anti-Bacterial Agents |
Displaying drugs 2201 - 2225 of 2785 in total